Hot Research: Lilly's Mounjaro Beats Novo's Ozempic in Weight Loss, Study Says. The Stocks Battle It Out. -- Barrons.com
Hot Research: Lilly's Mounjaro Beats Novo's Ozempic in Weight Loss, Study Says. The Stocks Battle It Out. -- Barrons.com
热门研究：莉莉的Mounjaro在减肥方面击败诺和诺的Ozempic，股票大战 - Barrons.com
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册